Literature DB >> 23612195

Gram-negative bacteria that produce carbapenemases causing death attributed to recent foreign hospitalization.

Jasmine Ahmed-Bentley1, A Uma Chandran, A Mark Joffe, Desiree French, Gisele Peirano, Johann D D Pitout.   

Abstract

Overseas travel, as a risk factor for the acquisition of infections due to antimicrobial-resistant organisms, has recently been linked to carbapenemase-producing Gram-negative bacteria. Multiresistant Klebsiella pneumoniae, Escherichia coli, and Acinetobacter baumannii strains were isolated from a wound of a Canadian patient with a recent history of hospitalization in India. This resulted in the initiation of outbreak management that included surveillance cultures. Epidemiological and molecular investigations showed that NDM-1-producing K. pneumoniae ST16 and OXA-23-producing A. baumannii ST10 strains were transmitted to 5 other patients, resulting in the colonization of 4 patients and the death of 1 patient due to septic shock caused by the OXA-23-producing A. baumannii strain. The high rate of false positivity of the screening cultures resulted in additional workloads and increased costs for infection control and clinical laboratory work. We believe that this is the first report of an infection with carbapenemase-producing Gram-negative bacteria resulting in death attributed to a patient with recent foreign hospitalization. We recommend routine rectal and wound screening for colonization with multiresistant bacteria for patients who have recently been admitted to hospitals outside Canada.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23612195      PMCID: PMC3697334          DOI: 10.1128/AAC.00297-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  43 in total

1.  Establishment of a universal size standard strain for use with the PulseNet standardized pulsed-field gel electrophoresis protocols: converting the national databases to the new size standard.

Authors:  Susan B Hunter; Paul Vauterin; Mary Ann Lambert-Fair; M Susan Van Duyne; Kristy Kubota; Lewis Graves; Donna Wrigley; Timothy Barrett; Efrain Ribot
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

2.  Use of Etest MBL strips for the detection of carbapenemases in Acinetobacter baumannii.

Authors:  Heidi Segal; B Gay Elisha
Journal:  J Antimicrob Chemother       Date:  2005-07-26       Impact factor: 5.790

3.  qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States.

Authors:  A Robicsek; J Strahilevitz; D F Sahm; G A Jacoby; D C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

4.  Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase.

Authors:  Ari Robicsek; Jacob Strahilevitz; George A Jacoby; Mark Macielag; Darren Abbanat; Chi Hye Park; Karen Bush; David C Hooper
Journal:  Nat Med       Date:  2005-12-20       Impact factor: 53.440

Review 5.  Resistance in gram-negative bacteria: Enterobacteriaceae.

Authors:  David L Paterson
Journal:  Am J Infect Control       Date:  2006-06       Impact factor: 2.918

6.  Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii.

Authors:  M Afzal-Shah; N Woodford; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

7.  Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates.

Authors:  Laure Diancourt; Virginie Passet; Jan Verhoef; Patrick A D Grimont; Sylvain Brisse
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

Review 8.  Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.

Authors:  L Poirel; P Nordmann
Journal:  Clin Microbiol Infect       Date:  2006-09       Impact factor: 8.067

9.  Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.

Authors:  Neil Woodford; Matthew J Ellington; Juliana M Coelho; Jane F Turton; M Elaina Ward; Susan Brown; Sebastian G B Amyes; David M Livermore
Journal:  Int J Antimicrob Agents       Date:  2006-03-24       Impact factor: 5.283

10.  Emergence of OXA-48-producing Klebsiella pneumoniae and the novel carbapenemases OXA-244 and OXA-245 in Spain.

Authors:  Jesús Oteo; Juan Manuel Hernández; Mateu Espasa; Ana Fleites; David Sáez; Verónica Bautista; María Pérez-Vázquez; Ma Dolores Fernández-García; Alberto Delgado-Iribarren; Isabel Sánchez-Romero; Luisa García-Picazo; Ma Dolores Miguel; Sonia Solís; Esteban Aznar; Gloria Trujillo; Concepción Mediavilla; Dionisia Fontanals; Susana Rojo; Ana Vindel; José Campos
Journal:  J Antimicrob Chemother       Date:  2012-10-02       Impact factor: 5.790

View more
  19 in total

1.  A multidrug resistance plasmid contains the molecular switch for type VI secretion in Acinetobacter baumannii.

Authors:  Brent S Weber; Pek Man Ly; Joshua N Irwin; Stefan Pukatzki; Mario F Feldman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-13       Impact factor: 11.205

Review 2.  Novel antimicrobial development using genome-scale metabolic model of Gram-negative pathogens: a review.

Authors:  Wan Yean Chung; Yan Zhu; Mohd Hafidz Mahamad Maifiah; Naveen Kumar Hawala Shivashekaregowda; Eng Hwa Wong; Nusaibah Abdul Rahim
Journal:  J Antibiot (Tokyo)       Date:  2020-09-08       Impact factor: 2.649

Review 3.  Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia.

Authors:  Li-Yang Hsu; Anucha Apisarnthanarak; Erum Khan; Nuntra Suwantarat; Abdul Ghafur; Paul Anantharajah Tambyah
Journal:  Clin Microbiol Rev       Date:  2016-10-19       Impact factor: 26.132

4.  New PCR-based open reading frame typing method for easy, rapid, and reliable identification of Acinetobacter baumannii international epidemic clones without performing multilocus sequence typing.

Authors:  Masahiro Suzuki; Eriko Hosoba; Mari Matsui; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2014-06-04       Impact factor: 5.948

5.  Travel-related carbapenemase-producing Gram-negative bacteria in Alberta, Canada: the first 3 years.

Authors:  Gisele Peirano; Jasmine Ahmed-Bentley; Jeff Fuller; Joseph E Rubin; Johann D D Pitout
Journal:  J Clin Microbiol       Date:  2014-03-05       Impact factor: 5.948

6.  Epidemiologic and Genotypic Review of Carbapenemase-Producing Organisms in British Columbia, Canada, between 2008 and 2014.

Authors:  Inna Sekirov; Matthew A Croxen; Corrinne Ng; Robert Azana; Yin Chang; Laura Mataseje; David Boyd; Chand Mangat; Benjamin Mack; Manal Tadros; Elizabeth Brodkin; Pamela Kibsey; Aleksandra Stefanovic; Sylvie Champagne; Michael R Mulvey; Linda M N Hoang
Journal:  J Clin Microbiol       Date:  2015-11-25       Impact factor: 5.948

7.  Azidothymidine Produces Synergistic Activity in Combination with Colistin against Antibiotic-Resistant Enterobacteriaceae.

Authors:  Yanmin Hu; Yingjun Liu; Anthony Coates
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

8.  Colistin-Nonsusceptible Pseudomonas aeruginosa Sequence Type 654 with blaNDM-1 Arrives in North America.

Authors:  L F Mataseje; G Peirano; D L Church; J Conly; M Mulvey; J D Pitout
Journal:  Antimicrob Agents Chemother       Date:  2016-01-11       Impact factor: 5.191

9.  Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates in the Gulf Cooperation Council States: dominance of OXA-23-type producers.

Authors:  Hosam M Zowawi; Anna L Sartor; Hanna E Sidjabat; Hanan H Balkhy; Timothy R Walsh; Sameera M Al Johani; Reem Y AlJindan; Mubarak Alfaresi; Emad Ibrahim; Amina Al-Jardani; Jameela Al Salman; Ali A Dashti; Khalid Johani; David L Paterson
Journal:  J Clin Microbiol       Date:  2015-01-07       Impact factor: 5.948

10.  First description of NDM-1-, KPC-2-, VIM-2- and IMP-4-producing Klebsiella pneumoniae strains in a single Chinese teaching hospital.

Authors:  Y Liu; L-G Wan; Q Deng; X-W Cao; Y Yu; Q-F Xu
Journal:  Epidemiol Infect       Date:  2014-04-24       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.